Last reviewed · How we verify

NCT03284190: SMASH

Scandinavian Multicentre Acute Subdural Hematoma (SMASH) Study

Status unknown Last updated 6 March 2018
What this trial tests

trial testing Surgery in Acute Subdural Hematoma in 1,600 participants. Status unknown.

Timeline
6 March 2018
Primary endpoint
1 October 2018
1 December 2018

Quick facts

Lead sponsorKarolinska University Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,600
Start date6 March 2018
Primary completion1 October 2018
Estimated completion1 December 2018

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska University Hospital

Who can join

Eligibility, any sex, with Acute Subdural Hematoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In a multi-national population-based cohort, the investigators want to compare the clinical course and clinical outcome of elderly patients (≥70 y/o) compared with younger patients (\< 70 y/o) with acute subdural hematoma treated surgically. An improved understanding of the clinical outcome and the prognostic factors of acute subdural hematomas would allow physicians to make better decisions about treatment options in traumatic ASDH in the elderly population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Scandinavian Multicenter Acute Subdural Hematoma (SMASH) Study: Study Protocol for a Multinational Population-Based Consecutive Cohort.
    Bartek J, Laugesen C, Mirza S, Forsse A, et al · · 2019 · cited 4× · PMID 29762769 · DOI 10.1093/neuros/nyy173

Verify or expand the search:

Other trials of Surgery

Trials testing the same drug.

Other Karolinska University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03284190.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing